Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Library Archives
Volume 25, 2021 Archive

Six issues from 2021 in one convenient archive.

  • Full-color, full-text PDF files of articles and formulations from the Journal.
  • Print or save articles for your research, marketing, and educational needs.
  • Log-in to your account for keyword or topical search and download.
  • Purchased items appear with download icon in contents and search results.

Only $30000


(Select Format)
Instant Online Access

This archive contains the following articles listed by volume, issue and page number:

Issues Included
Issue/Volume Title
January/February 2021
Vol. 25 No. 1
Volume 25, Number 1
March/April 2021
Vol. 25 No. 2
Volume 25, Number 2
May/June 2021
Vol. 25 No. 3
Volume 25, Number 3
July/August 2021
Vol. 25 No. 4
Volume 25, Number 4
September/October 2021
Vol. 25 No. 5
Volume 25, Number 5
November/December 2021
Vol. 25 No. 6
Volume 25, Number 6

Volume 25, 2021 Articles
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
PreScription: The NASEM cBHT Report, Part 2
Allen Loyd V Jr
Jan/Feb 2021
Pg. 4

Cleanroom Cleanliness
Mulder Kyle
Jan/Feb 2021
Pg. 6-12

Gender Bias in the Treatment of Menopausal Women: I am Hot as Hell and Not Going to Take It Anymore, Part 2
DeRosa Angela
Jan/Feb 2021
Pg. 14-17

Reversing Erectile Dysfunction and Urinary Incontinence After Prostatectomy or Radiotherapy: The Stanley Prostate-Cancer Treatment Protocol
McKettrick Greg
, Yoch Doug
Jan/Feb 2021
Pg. 18-23

Case Report: The Quest for a Palatable Compounded Metronidazole (Base) Suspension
McElhiney Linda F
Jan/Feb 2021
Pg. 24-28

Intravenous Admixture Preparation Considerations, Part 8: Ready-to-Use Preparations
Allen Loyd V Jr
Jan/Feb 2021
Pg. 31-38

Calculations
Stockton Shelly J
Jan/Feb 2021
Pg. 40

Acetaminophen (Paracetamol) 50 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Jan/Feb 2021
Pg. 42

Amlodipine Besylate 0.5-mg/mL to 10-mg/mL in SuspendIt Oral Suspension
Allen Loyd V Jr
Jan/Feb 2021
Pg. 43

Clonidine 0.01-mg/mL in Oral Mix and Oral Mix SF Suspension
Allen Loyd V Jr
Jan/Feb 2021
Pg. 44

Cyclophosphamide 10 mg/mL in Oral-Plus or Simple Syrup Suspension
Allen Loyd V Jr
Jan/Feb 2021
Pg. 45

Diclofenac Sodium 5 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Jan/Feb 2021
Pg. 46

Metronidazole 50-mg/mL in Oral Mix and Oral Mix SF Suspension
Allen Loyd V Jr
Jan/Feb 2021
Pg. 47

Design and Performance of an Inexpensive Water Activity Meter
Gilda Sagar S
, Schober Joseph M, McPherson Timothy
Jan/Feb 2021
Pg. 48-51

Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration
Lu Juan
, Liu Qiang, Kupiec Thomas C, Vail Herbert, Lynch Leslie R, Fam David S, Vu Nicole T
Jan/Feb 2021
Pg. 52-61

Formulation and Pharmaceutical Evaluation of Extemporaneous α-arbutin Creams for the Treatment of Melasma
Teeranachaideekul Veerawat
, Boonsongsawat Worrawee, Asanawittaya Waralee, Jintapattanakit Anchalee, Chantasart Doungdaw, Wongrakpanich Amaraporn
Jan/Feb 2021
Pg. 62-72

Beyond-use Date of Trimix: A Reproducible Stability Study Using Bracketing Design
Patel Gopesh
, Davis Countaney, Liu Yi, Ip Kendice, Debideen Krystal E, Anderson Stephanie, Byrne Robert, Herr Dylan, Rhoads Melissa Merrell, Caputo Ross, Banov Daniel, Bassani August S
Jan/Feb 2021
Pg. 73-81

Physical-chemical Stability of Compounded Sildenafil 100-mg Rapid-dissolving Tablets
Cheung Matthew
, Zhao Fang, Dave Vivek S
Jan/Feb 2021
Pg. 82-87

PreScription: The Past (-->2020), The Present, and The Future (2021-->)
Allen Loyd V Jr
Mar/Apr 2021
Pg. 92

The Stanley Prostate-cancer Treatment Protocol for Erectile Dysfunction After Prostatectomy and/or Radiotherapy: A Case Report
McKettrick Greg
, Yoch Doug
Mar/Apr 2021
Pg. 94-98

Compounding Pearls -- Wound Care: Drugs and Formulations for Dermal Healing
Riepl Mike
Mar/Apr 2021
Pg. 100-103

Experimental Multidisciplinary Approach Based on Compounded Capsule's Quality Evaluation for Pharmacy Undergraduate Courses
dos Santos Matheus Skrcek Ribeiro
, de Lima Amanda Muniz dos Santos, Christoff Adriana de Oliveira, Teixeira Mariana Lopes, Carneiro Jaqueline
Mar/Apr 2021
Pg. 104-108

Descriptive Report of Individual State Responses to Personal Protective Equipment Shortages for Pharmacy Practice During the Covid-10 Pandemic
Roberts Patricia A
, Eberwein Samuel M, Youmans Danielle, Amerine Lindsey B
Mar/Apr 2021
Pg. 109-113

Quality Control: Minor Chapters, Major Impacts: What United States Pharmacopeia Chapters <51>, <61>, <62>, and <1207> Mean for Your Compounding Practice
Kelley Brian
Mar/Apr 2021
Pg. 115-124

Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 8: Humectants
Allen Loyd V Jr
Mar/Apr 2021
Pg. 126-128

Intravenous Admixture Preparation Considerations, Part 9-A: Error Prevention in Intravenous Admixture Preparation
Allen Loyd V Jr
Mar/Apr 2021
Pg. 131-139

Calculations
Stockton Shelly J
, Bui Phi H
Mar/Apr 2021
Pg. 140-141

Amlodipine 1-mg/mL in Oral Mix Suspension
Allen Loyd V Jr
Mar/Apr 2021
Pg. 142

Canine Soft Chew Base (Veterinary)
Allen Loyd V Jr
Mar/Apr 2021
Pg. 143

Eslicarbazepine Acetate 40-mg/mL in Ora-Plus with Ora-Sweet or Ora-Sweet SF Suspension
Allen Loyd V Jr
Mar/Apr 2021
Pg. 144

Levodopa/Carbidopa 5.0/1.25 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Mar/Apr 2021
Pg. 145

In Vitro Permeability, Irritability, and Release Evaluation of Commonly Used Topical Diclofenac Gel Preparations (1%, 5%, and 10%)
Kohan Hamed Gilzad
, Baker David M, Sani Shabnam, Bielecki-Wilken Kathleen A, Ramirez Alfonso
Mar/Apr 2021
Pg. 146-155

Stability of Fagron's Phytobase Cream Compounded with Various Hormones
Wynn Tom
, Taylor Sarah, Zander Clark
Mar/Apr 2021
Pg. 156-162

Stability of Extemporaneously Compounded Nadolol 10-mg/mL Suspension in Oral Mix in Glass and Plastic Bottles and Plastic Syringes
Walsh Andrea
, Ziegler Blake, Lingertat-Walsh Karen, Law Shirley, Walker Scott E
Mar/Apr 2021
Pg. 163-168

Physicochemical and Microbiological Stability of Compounded Metronidazole Suspensions in PCCA SuspendIt
Pramar Yashoda V
, Mandal Tarun K, Bostanian Levon A, Le Giang, Morris Tommy C, Graves Richard A
Mar/Apr 2021
Pg. 169-175

PreScription: The Ethical Pharmacist
Allen Loyd V Jr
May/Jun 2021
Pg. 180

Pharmacy Technicians' Perceptions of Risk Reduction Strategies Implemented in Response to the Repetitive Strain Injury Associated with Sterile Compounding
Zamani Mazdak
, Chan Kayin, Wilcox Julie
May/Jun 2021
Pg. 182-186

Insurance Considerations for the Pharmacy Professional
Jones Kirsten
May/Jun 2021
Pg. 190-195

A Simplified Method for Compounding Lidocaine Topical Gel: A Demonstration of Quality Assurance to Prevent Errors in 503A Pharmacies
Hall Essence
, Levesque Dan, Rashid Mamoon, Mullins Randy, Hossain Mohammad Faisal
May/Jun 2021
Pg. 197-204

FDA-funded Report on Compounded Hormones is Tainted, Analysis Shows
Brunner Scott
May/Jun 2021
Pg. 206-209

Quality Control: Testing for "Micromonsters": Viable Air and Surface Sampling in Aseptic Compounding
Mulder Kyle
May/Jun 2021
Pg. 211-216

Basics of Compounding: Excipients Used in Nonsterile Compounding: Diluents
Allen Loyd V Jr
May/Jun 2021
Pg. 218-221

Intravenous Admixture Preparation Considerations, Part 9-B: Error Prevention in Intravenous Admixture Preparation
Allen Loyd V Jr
May/Jun 2021
Pg. 222-229

Calculations
Stockton Shelly J
May/Jun 2021
Pg. 230-231

Levofloxacin 50-mg/mL in Ora-Plus and Strawberry Syrup Suspension
Allen Loyd V Jr
May/Jun 2021
Pg. 232

Naltrexone Hydrochloride 0.5 mg/mL and 5.0 mg/mL in SuspendIt Suspension
Allen Loyd V Jr
May/Jun 2021
Pg. 233

Tacrolimus 0.5 mg/mL in Ora-Plus and Simple Syrup Suspension
Allen Loyd V Jr
May/Jun 2021
Pg. 234

Temozolomide 10 mg/mL in Oral Mix SF Suspension
Allen Loyd V Jr
May/Jun 2021
Pg. 235

Stability Evaluation of Minoxidil in FOAMIL Form Base with Bracketing Study Design
Lupatini Rodrigo
, Sidhu Raman, Patel Harshad, Bichar Katia
May/Jun 2021
Pg. 236-240

In Vitro Release Tests of Ketoprofen from Pluronic Lecithin Organogel versus Lipoderm Using Immersion Cells and the Phoenix DB-6 Dry Heat Diffusion Tester
McKinney Rachael D
, Dunbar Jacob R
May/Jun 2021
Pg. 241-245

Prolonged In-use Stability of Diluted Atezolizumab in Commercial Intravenous Bags
Hui Ada
, Yin Jian, Liu Wei, Zheng Kai
May/Jun 2021
Pg. 246-257

Study on the Optimal Conditions for Long-term Storage of Melatonin Powder as an In-hospital Preparation
Odanaka Keita
, Kojima Hiroki, Nakagawa Naoto
May/Jun 2021
Pg. 258-262

PreScription: Endemics, Epidemics, and Pandemics
Allen Loyd V Jr
Jul/Aug 2021
Pg. 268

Growing a Compounding Practice: Successful Marketing to Underserved Populations
McKettrick Greg
, Yoch Doug
Jul/Aug 2021
Pg. 270-274

Expecting the Expected: Planning Considerations for Cleanroom Construction
Roberts Patricia A
, Kroon Laura
Jul/Aug 2021
Pg. 276-281

Compounding Pearls -- Wound Care: Drugs and Formulations for Dermal Healing, Part 2
Riepl Mike
Jul/Aug 2021
Pg. 282-287

Safety Aspects of Extemporaneous Prescriptions Prescribed by Latvian Healthcare Specialists
Kiselova Olga
, Maurina Baiba, Sidlovska Venta
Jul/Aug 2021
Pg. 288-295

A Permanent Path for Urgent-use Compounding? APC-supported Legislation Would Allow 503As to Fill Gaps in Coverage When 503Bs Cannot
Brunner Scott
Jul/Aug 2021
Pg. 296-297

Quality Control: How to Produce a Well-closed Sealed Vial in a Regulated CGMP Environment: Part 1
Higgins Doral (Neal) O
, Prudom Melanie J, Summers Amy
Jul/Aug 2021
Pg. 298-302

Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 10: Rectal Suppository Bases
Allen Loyd V Jr
Jul/Aug 2021
Pg. 304-309

Basics of Sterile Compounding: Intravenous Admixture Preparation Considerations, Part 10: Packaging and Container-closure Issues
Allen Loyd V Jr
Jul/Aug 2021
Pg. 311-317

Calculations
Stockton Shelly J
Jul/Aug 2021
Pg. 318

Apixaban 0.25-mg/mL Suspension for Enteral Feeding Tube
Allen Loyd V Jr
Jul/Aug 2021
Pg. 320

Atomoxetine 4-mg/mL Oral Solution/Suspension
Allen Loyd V Jr
Jul/Aug 2021
Pg. 321

BHR in PLO Gel (Benadryl, Haldol, and Reglan in Pluronic Lecithin Organogel)
Allen Loyd V Jr
Jul/Aug 2021
Pg. 322

Budesonide 0.0.25% Mucoadhesive Gel
Allen Loyd V Jr
Jul/Aug 2021
Pg. 323

Cyclopentolate Hydrochloride 0.5%, Phenylephrine HCl 2.5%, and Tropicamide 0.5% Ophthalmic Solution
Allen Loyd V Jr
Jul/Aug 2021
Pg. 324

Hydrocortisone 2-mg/mL in Oral Mix Suspension
Allen Loyd V Jr
Jul/Aug 2021
Pg. 325

Moh's Paste, Modified
Allen Loyd V Jr
Jul/Aug 2021
Pg. 326

Nifedipine 4.mg/mL in SyrSpend SF pH4 Cherry Flavored
Allen Loyd V Jr
Jul/Aug 2021
Pg. 327

Tacrolimus 0.1% Topical Microemulsion
Allen Loyd V Jr
Jul/Aug 2021
Pg. 328

Valsartan 4-mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Jul/Aug 2021
Pg. 329

Stability of Dexmedetomidine in Polyvinyl Chloride Bags Containing 0.9% Sodium Chloride Intended for Subcutaneous Infusions
Wolfe Amanda
, Zhang Jeremy, Lapenskie Julie, Downar James, Kanji Salmaan
Jul/Aug 2021
Pg. 330-335

Compatibility of Estradiol, Estriol, Estrone, Progesterone, and Testosterone Single Formulation in Fitalite, Versatile, or HRT Supreme Cream Base
Polonini Hudson C
, Dijkers Eli, Ferreira Anderson O, Zander Clark, Taylor Sarah
Jul/Aug 2021
Pg. 336-343

Stability of Compounded Topical Nifedipine in Cream, Gel, and Ointment Bases
Teimouri Arezou
, Yeung Pollen, Agu Remigius U
Jul/Aug 2021
Pg. 344-351

PreScription: Permissible Exposure Limits and United States Pharmacopeia Chapter <800>
Allen Loyd V Jr
Sep/Oct 2021
Pg. 356

Determining Whether a Substance is Legal to Compound with Under Section 503A of the FDCA
Cabaleiro Joe
Sep/Oct 2021
Pg. 358-362

Filling the Gaps on the Institute for Safe Medication Practices (ISMP) Do Not Crush List for Immediate-release Products
Uttaro Elizabeth
, Zhao Fang, Schweighardt Anne
Sep/Oct 2021
Pg. 364-371

Compounding Pearls--Wound Care: Drugs and Formulations for Dermal Healing, Part 3: The Roles of Nitric Oxide, Sildenafil, and Naltrexone
Riepl Mike
Sep/Oct 2021
Pg. 372-377

Realities of Pharmaceutical Compounding in the Republic of Uzbekistan
Umarov Ulugbek
, Zdoryk Oleksandr, Kolisnyk Sergii, Fatkhullaeva Muyussar
Sep/Oct 2021
Pg. 378-384

It's Time for a New Philosophy
Brunner Scott
Sep/Oct 2021
Pg. 386-387

Quality Control: How to Produce a Well-closed Sealed Vial in a Regulated CGMP Environment: Part 2
Higgins Doral (Neal) O
, Prudom Melanie J, Summers Amy
Sep/Oct 2021
Pg. 389-395

Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 11: Drug Tastes: Innate, Induced, and Improved
Allen Loyd V Jr
Sep/Oct 2021
Pg. 396-400

Basics of Sterile Compounding: Intravenous Admixture Preparation, Part 11: Particulate Issues --- Silicone Oil in Vials, Cartridges, and Syringes
Allen Loyd V Jr
Sep/Oct 2021
Pg. 403-408

Calculations
Stockton Shelly J
Sep/Oct 2021
Pg. 410

Atropine Sulfate 0.1 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
Sep/Oct 2021
Pg. 412

Cilazapril 1-mg/mL in Ora-Blend Suspension
Allen Loyd V Jr
Sep/Oct 2021
Pg. 413

Clonidine 0.01-mg/mL in Ora-Blend Suspension
Allen Loyd V Jr
Sep/Oct 2021
Pg. 414

Dapsone 2-mg/mL in Oral Mix or Oral Mix SF Suspension
Allen Loyd V Jr
Sep/Oct 2021
Pg. 415

Dexamethasone 1-mg/mL in Oral Mix or Oral Mix SF Suspension
Allen Loyd V Jr
Sep/Oct 2021
Pg. 416

Haloperidol 0.5-mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Sep/Oct 2021
Pg. 417

Imipramine Hydrochloride 5-mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Sep/Oct 2021
Pg. 418

Mycophenolate Mofetil 50-mg/mL in Ora-Plus:Cherry Syrup Suspension
Allen Loyd V Jr
Sep/Oct 2021
Pg. 419

Sorafenib 20-mg/mL in Oil Oral Suspension
Allen Loyd V Jr
Sep/Oct 2021
Pg. 420

Spironolactone 2-mg/mL or 2-5.mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Sep/Oct 2021
Pg. 421

Compatibility of Gestrinone, Nimesulide, and Piroxicam in Pentravan for Transdermal and Transmucosal Application
Polonini Hudson
, de Oliveira Ferreira Anderson, Dijkers Eli
Sep/Oct 2021
Pg. 422-426

Stability of Diazepam Enema Extemporaneous Formulation in Manzoni Base
Lopalco Antonio
, Lopedota Angela, Aurelio Fiorenza, la Forgia Flavia, Fontana Sergio, Franco Massimo, Denora Nunzio
Sep/Oct 2021
Pg. 427-430

Physicochemical and Microbiological Stability of Extemporaneously Compounded Hydrocortisone Oral Suspensions in PCCA Base, SuspendIt
Pramar Yashoda V
, Mandal Tarun K, Bostanian Levon A, Kader Cyndy, Morris Tommy C, Graves Richard A
Sep/Oct 2021
Pg. 431-439

PreScription: IJPC -- Twenty-Five Year Anniversary
Allen Loyd V Jr
Nov/Dec 2021
Pg. 444

Microwave Freeze-thaw Technique for Injectable Drugs: A Review Updated from 1980 to 2021
Hecq Jean-Daniel
, Soumoy Laura, Closset Mélanie, Colsoul Marie-Lise, Jamart Jacques, Galanti Laurence
Nov/Dec 2021
Pg. 446-462

Glycopyrrolate Sorbitol Lollipops for Drooling: Two Case Reports
Agbi Kelechi E
, Carvalho Maria, Vieira-Banov Fabiana
Nov/Dec 2021
Pg. 464-467

Compounding Pearls -- Wound Care: Drugs and Formulations for Dermal Healing, Part 4. Insulin
Riepl Mike
Nov/Dec 2021
Pg. 468-472

Hospital Compounding in Nigeria: A Review of Needs, Practice, and Suggestions for Pharmaceutical Dispensing Ciurriculum Development
Orubu Ebiowei Samuel F
, Patani Bernard Opatimidi, Arhewoh Matthew Ikhuoria
Nov/Dec 2021
Pg. 475-481

Case Reports on the Use of Aloe Vera, Naltrexone, and Topiramate for the Treatment of Scars
Harris Kylie
, Wright Edward
Nov/Dec 2021
Pg. 482-485

Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 12: Sorbents (Adsorbents and Absorbents)
Allen Loyd V Jr
Nov/Dec 2021
Pg. 486-489

Basics of Sterile Compounding: Intravenous Admixture Preparation, Part 12: United States Pharmacopeia Chapters Referenced in the Current United States Pharmacopeia Chapter <797> Pharmaceutical Compounding -- Sterile Preparations
Allen Loyd V Jr
Nov/Dec 2021
Pg. 491-496

Calculations
Stockton Shelly J
Nov/Dec 2021
Pg. 498

Domperidone 5 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Nov/Dec 2021
Pg. 500

Kayexalate in Lactulose
Allen Loyd V Jr
Nov/Dec 2021
Pg. 501

Levetiracetam 50 mg/mL in Ora-Sweet and Ora-Plus Suspension
Allen Loyd V Jr
Nov/Dec 2021
Pg. 502

Metoprolol Tartrate 10 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
Nov/Dec 2021
Pg. 503

Propranolol 2 mg/mL or 5 mg/mL in Ora-Sweet
Allen Loyd V Jr
Nov/Dec 2021
Pg. 504

Pyridoxine Hydrochloride 25 mg/mL in Oral Mix and Oral Mix SF Suspension
Allen Loyd V Jr
Nov/Dec 2021
Pg. 505

Quetiapine Fumarate 10 mg/mL in Ora-Blend
Allen Loyd V Jr
Nov/Dec 2021
Pg. 506

Shari's Burn Cream
Allen Loyd V Jr
Nov/Dec 2021
Pg. 507

Sulfadiazine 100 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Nov/Dec 2021
Pg. 508

Ziprasidone Mesylate 2.5 mg/mL in Ora-Sweet Suspension
Allen Loyd V Jr
Nov/Dec 2021
Pg. 509

Compounding Robots for Intravenous Therapy in European Countries: A Review in 2020
Hecq Jean-Daniel
, Soumoy Laura
Nov/Dec 2021
Pg. 510-514

Evaluation of Closed-system Transfer Devices in Reducing Potential Risk for Surface Contamination Following Simulated Hazardous-drug Preparation and Compounding
Soefje Scott
, Rickabaugh Keith, Rajkumar Rahul, Wall Kathryn P
Nov/Dec 2021
Pg. 515-522

Formulation, Physical Stability, and the Clinical Effectiveness of Extemporaneous Ivermectin Oral Solution
Zaid Abdel-Naser
, Zaaror Yara Abu, Qaddumi Aiman, Ratrout Ala, Ahmad Ayda, Hamad Emad, Kittana Naim
Nov/Dec 2021
Pg. 523-527

Return to Top